FTO and obesity disorder: On the one hand, FTO-mediated demethylation inhibits lipolysis and promotes the development of obesity through the sterol regulatory element-binding protein 1 c (SREBP1c) pathway, but on the other hand, it accelerates cholesterol efflux and inhibits atherosclerosis development through phosphorylation of AMPK [88].